| Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results JA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ... Ophthalmology 118 (12), 2453-2460, 2011 | 917 | 2011 |
| Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant JE Chang-Lin, M Attar, AA Acheampong, MR Robinson, SM Whitcup, ... Investigative ophthalmology & visual science 52 (1), 80-86, 2011 | 702 | 2011 |
| Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant DF Martin, BD Kuppermann, RA Wolitz, AG Palestine, H Li, CA Robinson, ... New England Journal of Medicine 340 (14), 1063-1070, 1999 | 594 | 1999 |
| Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema BD Kuppermann, MS Blumenkranz, JA Haller, GA Williams, DV Weinberg, ... Archives of ophthalmology 125 (3), 309-317, 2007 | 572 | 2007 |
| Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial JP Lalezari, RJ Stagg, BD Kuppermann, GN Holland, F Kramer, DV Ives, ... Annals of Internal Medicine 126 (4), 257-263, 1997 | 439 | 1997 |
| Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus--related noninfectious retinal vasculopathy in patients with … BD Kuppermann, JG Petty, DD Richman, WC Mathews, SC Fullerton, ... American journal of ophthalmology 115 (5), 575-582, 1993 | 420 | 1993 |
| Transforming growth factor-β2 for the treatment of full-thickness macular holes: a prospective randomized study BM Glaser, RG Michels, BD Kuppermann, RN Sjaarda, RA Pena Ophthalmology 99 (7), 1162-1173, 1992 | 420 | 1992 |
| Viral causes of the acute retinal necrosis syndrome JB Ganatra, D Chandler, C Santos, B Kuppermann, TP Margolis American journal of ophthalmology 129 (2), 166-172, 2000 | 404 | 2000 |
| Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema JA Haller, BD Kuppermann, MS Blumenkranz, GA Williams, DV Weinberg, ... Archives of Ophthalmology 128 (3), 289-296, 2010 | 392 | 2010 |
| Diabetic retinopathy and VEGF N Gupta, S Mansoor, A Sharma, A Sapkal, J Sheth, P Falatoonzadeh, ... The open ophthalmology journal 7, 4, 2013 | 378 | 2013 |
| Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant DC Musch, DF Martin, JF Gordon, MD Davis, BD Kuppermann, ... New England Journal of Medicine 337 (2), 83-90, 1997 | 377 | 1997 |
| Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications HF Edelhauser, CL Rowe-Rendleman, MR Robinson, DG Dawson, ... Investigative ophthalmology & visual science 51 (11), 5403-5420, 2010 | 325 | 2010 |
| Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema DG Callanan, S Gupta, DS Boyer, TA Ciulla, MA Singer, BD Kuppermann, ... Ophthalmology 120 (9), 1843-1851, 2013 | 273 | 2013 |
| Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome GA Williams, JA Haller, BD Kuppermann, MS Blumenkranz, DV Weinberg, ... American journal of ophthalmology 147 (6), 1048-1054. e2, 2009 | 236 | 2009 |
| Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema J Cunha-Vaz, P Ashton, R Iezzi, P Campochiaro, PU Dugel, FG Holz, ... Ophthalmology 121 (10), 1892-1903. e3, 2014 | 206 | 2014 |
| Comparison of intravitreal versus posterior sub–Tenon’s capsule injection of triamcinolone acetonide for diffuse diabetic macular edema JA Cardillo, LAS Melo Jr, RA Costa, M Skaf, R Belfort Jr, AA Souza-Filho, ... Ophthalmology 112 (9), 1557-1563, 2005 | 205 | 2005 |
| Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham … JS Heier, EM Lad, FG Holz, PJ Rosenfeld, RH Guymer, D Boyer, F Grossi, ... The Lancet 402 (10411), 1434-1448, 2023 | 204 | 2023 |
| Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes JE Chang-Lin, JA Burke, Q Peng, T Lin, WC Orilla, CR Ghosn, KM Zhang, ... Investigative ophthalmology & visual science 52 (7), 4605-4609, 2011 | 202 | 2011 |
| Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases MC Kenney, M Chwa, SR Atilano, P Falatoonzadeh, C Ramirez, D Malik, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (2), 208-219, 2014 | 197 | 2014 |
| Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells S Luthra, R Narayanan, LEA Marques, M Chwa, DW Kim, J Dong, ... Retina 26 (5), 512-518, 2006 | 193 | 2006 |
